Twenty-five years of follow-up in patients with operable breast carcinoma : Correlation between clinicopathologic factors and the risk of death in each 5-year period

The prognostic value of p53 and c-erb b-

The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years

✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly